| 000 | 01553 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250512200046.0 | ||
| 264 | 0 | _c19831028 | |
| 008 | 198310s 0 0 eng d | ||
| 022 | _a0006-2952 | ||
| 024 | 7 |
_a10.1016/0006-2952(83)90038-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJayaram, H N | |
| 245 | 0 | 0 |
_aConversion of 2-beta-D-ribofuranosylselenazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties. _h[electronic resource] |
| 260 |
_bBiochemical pharmacology _cSep 1983 |
||
| 300 |
_a2633-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aGas Chromatography-Mass Spectrometry |
| 650 | 0 | 4 |
_aIMP Dehydrogenase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aKetone Oxidoreductases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aLeukemia P388 _xdrug therapy |
| 650 | 0 | 4 |
_aLeukemia, Experimental _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNAD _xanalogs & derivatives |
| 650 | 0 | 4 | _aOrganoselenium Compounds |
| 650 | 0 | 4 |
_aRibavirin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aRibonucleosides _xchemical synthesis |
| 650 | 0 | 4 |
_aSelenium _xchemical synthesis |
| 700 | 1 | _aAhluwalia, G S | |
| 700 | 1 | _aDion, R L | |
| 700 | 1 | _aGebeyehu, G | |
| 700 | 1 | _aMarquez, V E | |
| 700 | 1 | _aKelley, J A | |
| 700 | 1 | _aRobins, R K | |
| 700 | 1 | _aCooney, D A | |
| 700 | 1 | _aJohns, D G | |
| 773 | 0 |
_tBiochemical pharmacology _gvol. 32 _gno. 17 _gp. 2633-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0006-2952(83)90038-2 _zAvailable from publisher's website |
| 999 |
_c6137305 _d6137305 |
||